These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 1697887
1. Monoamine receptors in an animal model of affective disorder. Martin JV, Edwards E, Johnson JO, Henn FA. J Neurochem; 1990 Oct; 55(4):1142-8. PubMed ID: 1697887 [Abstract] [Full Text] [Related]
2. Presynaptic serotonin mechanisms in rats subjected to inescapable shock. Edwards E, Kornrich W, Houtten PV, Henn FA. Neuropharmacology; 1992 Apr; 31(4):323-30. PubMed ID: 1387924 [Abstract] [Full Text] [Related]
3. 5-HT1b receptors in an animal model of depression. Edwards E, Harkins K, Wright G, Henn FA. Neuropharmacology; 1991 Jan; 30(1):101-5. PubMed ID: 2046876 [Abstract] [Full Text] [Related]
4. In vitro neurotransmitter release in an animal model of depression. Edwards E, Kornrich W, van Houtten P, Henn FA. Neurochem Int; 1992 Jul; 21(1):29-35. PubMed ID: 1303140 [Abstract] [Full Text] [Related]
5. Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats. Heinsbroek RP, van Haaren F, Feenstra MG, Boon P, van de Poll NE. Brain Res; 1991 Jun 14; 551(1-2):247-55. PubMed ID: 1913155 [Abstract] [Full Text] [Related]
6. On the role of adenylate cyclase in presynaptic modulation of neurotransmitter release mediated by monoamine and opioid receptors in the brain. Mulder AH, Schoffelmeer AN, Stoof JC. Ann N Y Acad Sci; 1990 Jun 14; 604():237-49. PubMed ID: 1977351 [No Abstract] [Full Text] [Related]
7. Neurochemical and behavioral consequences of mild, uncontrollable shock: effects of PCPA. Edwards E, Johnson J, Anderson D, Turano P, Henn FA. Pharmacol Biochem Behav; 1986 Aug 14; 25(2):415-21. PubMed ID: 2945212 [Abstract] [Full Text] [Related]
11. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Ben-Shachar D, Gazawi H, Riboyad-Levin J, Klein E. Brain Res; 1999 Jan 16; 816(1):78-83. PubMed ID: 9878693 [Abstract] [Full Text] [Related]
12. Central monoamines and convulsine thresholds in mice and rats. Kilian M, Frey HH. Neuropharmacology; 1973 Jul 16; 12(7):681-92. PubMed ID: 4730377 [No Abstract] [Full Text] [Related]
13. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA. J Pharmacol Exp Ther; 1988 Jan 16; 244(1):310-21. PubMed ID: 3336007 [Abstract] [Full Text] [Related]
14. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens. Boyd KE, Fitzpatrick DW, Wilson JR, Wilson LM. Can J Vet Res; 1988 Apr 16; 52(2):181-5. PubMed ID: 2453262 [Abstract] [Full Text] [Related]
15. Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment. Häidkind R, Eller M, Kask A, Harro M, Rinken A, Oreland L, Harro J. Neurochem Int; 2004 Oct 16; 45(5):721-32. PubMed ID: 15234115 [Abstract] [Full Text] [Related]
16. The effect of alpha-adrenergic receptor blockers prazosin and yohimbine on cerebral metabolism and biogenic amine content of traumatized brain. Inoue M, McHugh M, Pappius HM. J Cereb Blood Flow Metab; 1991 Mar 16; 11(2):242-52. PubMed ID: 1705253 [Abstract] [Full Text] [Related]
17. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM. Mol Pharmacol; 1985 Jun 16; 27(6):600-11. PubMed ID: 2860558 [Abstract] [Full Text] [Related]
18. Influence of supidimide on brain neurotransmitter systems of rats and mice. Hennies HH, Günzler WA, Flohé L. Arzneimittelforschung; 1984 Jun 16; 34(11):1471-80. PubMed ID: 6084511 [Abstract] [Full Text] [Related]
19. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration. Sherry-McKenna RL, Baker GB, Mousseau DD, Coutts RT, Dewhurst WG. Biol Psychiatry; 1992 May 01; 31(9):881-8. PubMed ID: 1353376 [Abstract] [Full Text] [Related]